Literature DB >> 4062197

Experimental rotavirus diarrhoea in colostrum-deprived newborn calves: assay of treatment by administration of bacterially produced human interferon (Hu-IFN alpha 2).

A Schwers, C Vanden Broecke, M Maenhoudt, J M Béduin, J Wérenne, P P Pastoret.   

Abstract

Seven colostrum-deprived newborn calves were orally inoculated within 24 hours after birth with bovine rotavirus. Three of them were intramuscularly injected with bacterially produced human interferon (Hu-IFN alpha 2). The four control animals presented a severe diarrhoea for at least 48 hours, while only one of the treated calves suffered from a transient diarrhoea for a few hours. Hu-IFN alpha 2 seems therefore able to control rotavirus diarrhoea in newborn calves, although it did not inhibit virus excretion and seroconversion in the treated animals. Moreover, the administration of endogenous interferon appeared to be well tolerated by newborn calves. The efficacy of human alpha 2 interferon for the treatment of this important virus infection of cattle seems thus well established.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4062197

Source DB:  PubMed          Journal:  Ann Rech Vet        ISSN: 0003-4193


  18 in total

1.  Interferon regulatory factor 3 is a cellular partner of rotavirus NSP1.

Authors:  Joel W Graff; Dana N Mitzel; Carla M Weisend; Michelle L Flenniken; Michele E Hardy
Journal:  J Virol       Date:  2002-09       Impact factor: 5.103

2.  Evidence for CD8+ T-cell immunity to murine rotavirus in the absence of perforin, fas, and gamma interferon.

Authors:  M A Franco; C Tin; L S Rott; J L VanCott; J R McGhee; H B Greenberg
Journal:  J Virol       Date:  1997-01       Impact factor: 5.103

Review 3.  Antiviral actions of interferons.

Authors:  C E Samuel
Journal:  Clin Microbiol Rev       Date:  2001-10       Impact factor: 26.132

4.  Gene expression pattern in Caco-2 cells following rotavirus infection.

Authors:  Mariela A Cuadras; Dino A Feigelstock; Sungwhan An; Harry B Greenberg
Journal:  J Virol       Date:  2002-05       Impact factor: 5.103

5.  Intestinal epithelia activate anti-viral signaling via intracellular sensing of rotavirus structural components.

Authors:  A H Frias; M Vijay-Kumar; J R Gentsch; S E Crawford; F A Carvalho; M K Estes; A T Gewirtz
Journal:  Mucosal Immunol       Date:  2010-07-21       Impact factor: 7.313

Review 6.  Rotavirus and reovirus modulation of the interferon response.

Authors:  Barbara Sherry
Journal:  J Interferon Cytokine Res       Date:  2009-09       Impact factor: 2.607

Review 7.  Rotaviruses: from pathogenesis to vaccination.

Authors:  Harry B Greenberg; Mary K Estes
Journal:  Gastroenterology       Date:  2009-05-07       Impact factor: 22.682

8.  Cytokines as mediators for or effectors against rotavirus disease in children.

Authors:  B Jiang; L Snipes-Magaldi; P Dennehy; H Keyserling; R C Holman; J Bresee; J Gentsch; R I Glass
Journal:  Clin Diagn Lab Immunol       Date:  2003-11

Review 9.  The role of type I interferons in intestinal infection, homeostasis, and inflammation.

Authors:  Hyeseon Cho; Brian L Kelsall
Journal:  Immunol Rev       Date:  2014-07       Impact factor: 12.988

Review 10.  The battle between rotavirus and its host for control of the interferon signaling pathway.

Authors:  Michelle M Arnold; Adrish Sen; Harry B Greenberg; John T Patton
Journal:  PLoS Pathog       Date:  2013-01-24       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.